Hester Biosciences Limited — Updates, 28-10-2024: Press Release

Hester Biosciences reported strong Q2 and H1 FY25 results, with standalone product sales rising by 12% and profits up by 38%. Consolidated sales grew by 21%, leading to a 108% increase in profit. The Animal Healthcare division contributed to growth, supported by robust demand in the dairy sector and new product launches. Hester's international subsidiaries showed improvement, enhancing profitability and operational efficiency. The company focuses on diversification and innovation within its product portfolio.